Canaccord lowered the firm’s price target on Progyny (PGNY) to $19 from $26 and keeps a Hold rating on the shares. The firm updated its model follwong Q4 results which suggests business trends appear stable but the uncertain outlook and environment keeps them cautious on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGNY: